Crispr Therapeutics Ag (CRSP)Director bought ~$1.16M
Simeon George, Director at Crispr Therapeutics Ag, bought ~$1.16M of Crispr Therapeutics Ag shares.
- ~$1.16M
- Approx. value · 22K sh @ $52.03
- 239K
- Holds after · shares reported
- Traded
- Jul 16, 2025
- Filed
- Jul 17, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 29, 2025InsiderOfficer sold ~$141K of CRSP shares in the open market
- Jul 16, 2025 · this disclosureInsiderDirector purchased ~$1.16M of CRSP shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Crispr Therapeutics Ag
For Crispr Therapeutics Ag, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRSP page.
Other recent filings by Simeon George, Director
- SEC Form 4 at Crispr Therapeutics Ag (CRSP)Jul 17, 2025
- SEC Form 4 at Crispr Therapeutics Ag (CRSP)Jul 17, 2025
The full history of Simeon George, Director is on the profile page.
How this filing works
Other disclosures at Crispr Therapeutics Ag
- SEC Form 4Oct 8, 2026
- SEC Form 144Oct 6, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRMay 15, 2026
Everything OQRO holds on this company is on its CRSP page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
